Research map: Hsp90 Inhibition on the Western Blot: N‐Terminal Versus C‐Terminal Inhibitors in Breast Cancer

Back to the article

Papers in this map

  1. The BCL-2 protein family: opposing activities that mediate cell death · Richard J. Youle · 2007 · 4709 citations · Cited by this paper
  2. A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer · 2026 · Related
  3. HSP90 and the chaperoning of cancer · Luke J. Whitesell · 2005 · 2515 citations · Cited by this paper
  4. Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria · 2026 · Related
  5. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 · Steven K. Hanks · 1995 · 2349 citations · Cited by this paper
  6. Exercise‐Induced Exerkines: Multi‐Nodal Suppression of the NLRP3 Inflammasome and Translational Potential · 2026 · Related
  7. The first 30 years of p53: growing ever more complex · Arnold J. Levine · 2009 · 2001 citations · Cited by this paper
  8. Advances in SIRT2‐Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader Technologies · 2026 · Related
  9. The HSP70 chaperone machinery: J proteins as drivers of functional specificity · Harm H. Kampinga · 2010 · 1823 citations · Cited by this paper
  10. AI‐Driven Multi‐Omics Integrated Applications Using Diverse Neural Networks for Breast Cancer Diagnostic Screening and Biomarker Discovery · 2026 · Related
  11. The EGFR family and its ligands in human cancer · Yosef Yarden · 2001 · 1591 citations · Cited by this paper
  12. FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application · 2025 · Related
  13. Emerging functions of the EGFR in cancer · Sara Sigismund · 2017 · 1517 citations · Cited by this paper
  14. Senotherapeutics for Knee Osteoarthritis · 2026 · Related
  15. The ErbB/HER family of protein-tyrosine kinases and cancer · Robert Jr. Roskoski · 2013 · 1366 citations · Cited by this paper
  16. Synthesis and Clinical Application of Small‐Molecule Drugs Approved by FDA in 2025 · 2026 · Related
  17. Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1 · Jiangying Zou · 1998 · 1251 citations · Cited by this paper
  18. The Potential, Challenges and New Horizons of Marine Natural Products Against Tuberculosis Infection · 2025 · Related
  19. Structure of TPR Domain–Peptide Complexes · Clemens Scheufler · 2000 · 1199 citations · Cited by this paper
  20. Advances in Structural Diversity, Pharmacological Activities, and Drug Development of β‐Carboline Alkaloids · 2026 · Related
  21. Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping · Xiaofeng Dai · 2017 · 1161 citations · Cited by this paper
  22. Estrogen receptor signaling mechanisms · Nathalie Fuentes · 2019 · 1010 citations · Cited by this paper
  23. Modulation of Akt kinase activity by binding to Hsp90 · Saori Sato · 2000 · 968 citations · Cited by this paper
  24. Specific protection against breast cancers by cyclin D1 ablation · Qunyan Yu · 2001 · 939 citations · Cited by this paper
  25. Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene · William S. Chen · 2001 · 931 citations · Cited by this paper
  26. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones · Xiao‐Bo Qiu · 2006 · 922 citations · Cited by this paper
  27. Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition · Mikko Taipale · 2012 · 920 citations · Cited by this paper
  28. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies · Md Entaz Bahar · 2023 · 873 citations · Cited by this paper
  29. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting · Liz J. Hernández Borrero · 2021 · 772 citations · Cited by this paper
  30. HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers · Marc L. Mendillo · 2012 · 737 citations · Cited by this paper
  31. BCL-2 family isoforms in apoptosis and cancer · Chloe Warren · 2019 · 732 citations · Cited by this paper
  32. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ · Robert S. Garofalo · 2003 · 723 citations · Cited by this paper
  33. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes · Rebecca Gupte · 2017 · 718 citations · Cited by this paper
  34. The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease · Abdullah Hoter · 2018 · 698 citations · Cited by this paper
  35. Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function · Andrea D. Basso · 2002 · 629 citations · Cited by this paper
  36. p53 signaling in cancer progression and therapy · Hany E. S. Marei · 2021 · 615 citations · Cited by this paper
  37. Role of PI3K/AKT pathway in cancer: the framework of malignant behavior · Ningni Jiang · 2020 · 598 citations · Cited by this paper
  38. The human HSP70 family of chaperones: where do we stand? · Jürgen Radons · 2016 · 594 citations · Cited by this paper
  39. The role of HER2 in cancer therapy and targeted drug delivery · Wanyi Tai · 2010 · 564 citations · Cited by this paper

Source: OpenAlex (CC0)